The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen
Research Funding - Eisai
EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.
 
Riccardo Lencioni
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Roche
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); EA Pharma (Inst); Eisai (Inst); GE Healthcare (Inst); Gilead Sciences (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Joseph Erinjeri
Consulting or Advisory Role - AstraZeneca
 
Shukui Qin
No Relationships to Disclose
 
Zhenggang Ren
Consulting or Advisory Role - AstraZeneca; MSD; Roche
 
Stephen Chan
No Relationships to Disclose
 
Yasuaki Arai
Speakers' Bureau - AstraZeneca; Boston Scientific; Canon Medical System; Cosmotec; Guerbet; Merit Medical Systems; Merit Medical Systems; Sumitomo Chemical; TERUMO
Patents, Royalties, Other Intellectual Property - Sumitomo Chemical
 
Jeong Heo
Consulting or Advisory Role - AstraZeneca/MedImmune
Speakers' Bureau - AstraZeneca/MedImmune; Roche
 
Ahn Mai
Research Funding - AstraZeneca
 
Jose Escobar
No Relationships to Disclose
 
Yamil Alonso Lopez Chuken
No Relationships to Disclose
 
Jung-Hwan Yoon
Research Funding - AstraZeneca; Dicerna; GlaxoSmithKline; Medivir; MSD; NewG Lab Pharma; Pharmicell; Roche; VIR Biotechnology
 
Won Young Tak
No Relationships to Disclose
 
Tanita Suttichaimongkol
Honoraria - Takeda
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Bayer; Roche; SIRTEX Medical
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Roche
 
Magdalena Żotkiewicz
Employment - AstraZeneca
 
Stephanie Udoye
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Gordon Cohen
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Roche/Genentech; Sirtex Medical; TERUMO
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Roche; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Roche; Sirtex Medical